Near Infrared Imaging Market by Product, Application, End User

List of Tables

[185 Pages Report] The Near Infrared Imaging Market size was estimated at USD 2.52 billion in 2023 and expected to reach USD 2.65 billion in 2024, at a CAGR 5.22% to reach USD 3.60 billion by 2030.

Near infrared imaging (NIRI) is a non-invasive diagnostic technology that utilizes near infrared light wavelengths from about 700 to 2500 nanometers, to capture images of biological tissues. NIR light can penetrate deeper into tissues, providing valuable information about the underlying structures and biochemical constituents. Advancements in detector technologies and the development of more advanced algorithms for image analysis are enhancing image quality in healthcare. The increasing number of surgical procedures requiring non-invasive diagnostics creates the need for NIR imaging. However, the technical limitations of NIRI can impede their utility across medical applications worldwide. Ongoing research is focused on the innovation of more sensitive detectors, enhanced algorithms for image processing, and the combination of NIRI with other imaging modalities, such as MRI or CT, to increase penetration depth and data accuracy. The rising trend in personalized medicine is expected to increase its applications in diagnostics and patient monitoring, and new applications in biometric security are emerging. The integration of NIRI with other technologies, such as wearable devices, promises continuous, real-time monitoring of health parameters.

KEY MARKET STATISTICS
Base Year [2023]	USD 2.52 billion
Estimated Year [2024]	USD 2.65 billion
Forecast Year [2030]	USD 3.60 billion
CAGR (%)	5.22%

Product: Introduction of advanced NIR imaging systems that provide real-time, high-resolution images

Near infrared (NIR) devices include a variety of instruments used for imaging in the medical field, such as cameras, video systems, and other visualization platforms. These devices provide real-time information that can be crucial during surgical procedures, such as blood flow visualization, tissue perfusion, and oxygenation. Near infrared optical coherence tomography (NIR-OCT) is a non-invasive imaging technique that uses near infrared light to capture micrometer-resolution and three-dimensional images from within optical scattering media. This technology is widely used in clinical and biomedical research for applications such as ophthalmology, which is essential for diagnosing retinal diseases, and cardiology, which is used for assessing vascular pathologies. Near infrared (NIR) spectrometers are analytical instruments that measure a sample's absorption, transmission, and reflectance of NIR light. They are employed in various industries, such as pharmaceuticals for quantifying active pharmaceutical ingredients, agriculture for assessing crop health and moisture content, and materials science for chemical composition analysis. NIR spectrometers are used for their rapid analysis capabilities, non-destructive nature, and ability to probe samples with little to no preparation. Dyes used in NIR imaging are compounds that fluoresce when exposed to near infrared light. These dyes are often used in conjunction with NIR devices to highlight specific tissues or structures during medical imaging. NIR reagents include various compounds that react with biological tissues to provide contrast in NIR imaging. These reagents can include probes, biomarkers, or other molecules that bind to specific cells or proteins, making them visible under NIR light. Clinicians opt for reagents offering high specificity and low background noise to isolate the areas of interest in diagnostic or intraoperative procedures.

Application: Exponential adoption of NIR imaging in cancer surgeries for accurate discrimination of cancerous tissues

Near infrared (NIR) imaging in cancer surgeries is a critical application where it is used to identify and delineate cancerous tissues from healthy tissues. It enables surgeons to visualize the blood flow, lymphatic systems, and key anatomical landmarks, thus assisting in precise tumor removal while sparing healthy tissue. In cardiovascular surgeries, NIR imaging is used to evaluate myocardial perfusion, assess bypass graft patency, and delineate cardiac anatomy. This application is essential to ensure the success of procedures, such as coronary artery bypass grafting (CABG), by providing real-time information on blood flow and tissue perfusion. NIR imaging in gastrointestinal surgeries assists in evaluating bowel perfusion, mapping lymph nodes, and conducting minimally invasive procedures. The technology is indispensable in surgeries such as colectomies and gastrectomies, where an accurate assessment of tissue viability is paramount. NIR imaging in plastic and reconstructive surgeries is primarily used for assessing tissue perfusion to ensure viability, particularly in the case of skin flaps and grafts. This application is crucial to prevent complications such as flap necrosis in breast reconstruction post-mastectomy or in complex wound management. Preclinical imaging utilizing NIR technology is an expanding field primarily used in research and developing new drugs and therapies. It allows non-invasive visualization of cellular and molecular processes in small animals, contributing to understanding disease mechanisms and the effects of therapeutic interventions. NIR imaging is particularly valuable in drug discovery and development, cancer research, and translational medicine, often chosen for its ability to provide real-time data and to reduce the need for invasive procedures in animal studies.

End User: Use of NIR technologies in hospitals and diagnostic centers to support clinical decision-making and improve patient care standards

In hospitals and clinics, near infrared imaging (NIRI) technology is primarily utilized for diagnostic and therapeutic procedures, such as angiography, plastic surgery, and intraoperative imaging to assist in surgeries. The need for NIRI in hospitals and clinics is also driven by the push for minimally invasive surgeries, which require precise imaging technologies. For pharmaceutical and biotechnology companies, near infrared imaging is a tool for drug discovery and development. It is particularly useful for studying biological processes in preclinical and clinical trials, allowing for real-time monitoring of drug distribution and metabolism. Research laboratories use near infrared imaging for a variety of applications, such as basic research in biology, chemistry, and materials science. Moreover, in diagnostic centers, NIR imaging is gaining popularity due to its non-invasive nature and the detailed information it can provide. Below are some of the key applications of NIR imaging in these facilities. The preference in this segment hinges on the versatility, sensitivity, and resolution of the imaging system, as researchers require tools that can adapt to diverse experimental conditions and provide detailed information on the molecular and cellular levels.

Regional Insights

In the Americas, specifically North America, there is a high adoption rate due to advanced healthcare infrastructure, significant investments in research and development (R&D), and stringent regulatory guidelines that promote the adoption of innovative technologies. Major companies in this region engage in strategic collaborations and maintain a robust production landscape to cater to the healthcare sector. The APAC region is witnessing rapid growth due to rising economic development, particularly in emerging countries, including China and India. Production is often driven by cost-effectiveness and increasing demand for near infrared imaging in medical diagnostics. Companies in APAC are focusing on expanding their product portfolio and enhancing distribution networks. The EMEA region, with a strong presence in countries such as Germany and the UK, balances mature markets in Europe with emerging ones in the Middle East and Africa. In Europe, there is a strong emphasis on quality and the integration of NIR imaging in scientific research, backed by supportive government initiatives. The Middle East and African markets are gradually adopting these technologies, often facilitated by foreign investments and partnerships for medical discoveries. Companies in EMEA are strategically positioning themselves to serve a diverse client base, taking advantage of Europe's technology orientation and the developing markets' growth opportunities.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Near Infrared Imaging Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Near Infrared Imaging Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Near Infrared Imaging Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Artinis Medical Systems, Astellas Pharma Inc., BIOPAC Systems, Inc., Biotium, Inc., Bruker Corporation, Carl Zeiss AG, Crysta-Lyn Chemical Company, DIC Corporation, Emberion Oy, Getinge AB, Hamamatsu Photonics K.K., KARL STORZ SE & Co. KG, Leica Microsystems GmbH by Danaher Corporation, LI-COR Biotech LLC, Malvern Panalytical Ltd. by Spectris PLC, Medtronic PLC, Metrohm AG, MIZUHO Corporation, Nikon Corporation, Olympus Corporation, OptoMedic Technologies, Inc., PerkinElmer Inc., SCHOLLY FIBEROPTIC GMBH, Shimadzu Corporation, Soterix Medical Inc., SpectraWAVE, Inc., Stryker Corporation, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Near Infrared Imaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Devices
  - Near-Infrared Bioluminescence Imaging Systems
  - Near-Infrared Fluorescence Imaging Systems
  - NIR Optical Coherence Tomography
  - NIR Spectrometers

Dyes
- Nanoparticle Dyes
- Organic Dyes

Reagents
- Indocyanine Green
- Methylene Blue

Application
- Cancer Surgeries
- Cardiovascular Surgeries
- Gastrointestinal Surgeries
- Plastic/Reconstructive Surgeries
- Preclinical Imaging

End User
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Research Laboratories

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - Massachusetts
    - Minnesota
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Near Infrared Imaging Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Near Infrared Imaging Market?

3. What are the technology trends and regulatory frameworks in the Near Infrared Imaging Market?

4. What is the market share of the leading vendors in the Near Infrared Imaging Market?

5. Which modes and strategic moves are suitable for entering the Near Infrared Imaging Market?

Product Code: MRR-433C4187C5E5

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing application in surgical procedures and intraoperative treatments
  - 5.1.1.2. Surging preference for non-invasive diagnostic methods worldwide
  - 5.1.1.3. Incorporation into consumer electronics for health monitoring
- 5.1.2. Restraints
  - 5.1.2.1. Technical limitations of NIR imaging systems
- 5.1.3. Opportunities
  - 5.1.3.1. Advancements in the design and performance of near infrared imaging
  - 5.1.3.2. Emerging use of NIR imaging for pharmaceutical quality control
- 5.1.4. Challenges
  - 5.1.4.1. Health hazards associated with NIR imaging
5.2. Market Segmentation Analysis
- 5.2.1. Product: Introduction of advanced NIR imaging systems that provide real-time, high-resolution images
- 5.2.2. Application: Exponential adoption of NIR imaging in cancer surgeries for accurate discrimination of cancerous tissues
- 5.2.3. End User: Use of NIR technologies in hospitals and diagnostic centers to support clinical decision-making and improve patient care standards
5.3. Market Trend Analysis
- 5.3.1. Advanced healthcare diagnostics infrastructure in the Americas and favorable approvals for NIR imaging
- 5.3.2. Increasing need for near infrared imaging due to the prevalence of chronic diseases along with improving healthcare infrastructure in the Asia-Pacific region
- 5.3.3. Adoption of near infrared imaging products to meet the disease diagnosis needs in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis

6. Near Infrared Imaging Market, by Product

6.1. Introduction
6.2. Devices
6.3. Dyes
6.4. Reagents

7. Near Infrared Imaging Market, by Application

7.1. Introduction
7.2. Cancer Surgeries
7.3. Cardiovascular Surgeries
7.4. Gastrointestinal Surgeries
7.5. Plastic/Reconstructive Surgeries
7.6. Preclinical Imaging

8. Near Infrared Imaging Market, by End User

8.1. Introduction
8.2. Hospitals & Clinics
8.3. Pharmaceutical & Biotechnology Companies
8.4. Research Laboratories

9. Americas Near Infrared Imaging Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Near Infrared Imaging Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Near Infrared Imaging Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
- 12.3.1. Abbott Launches New Vascular Imaging Platform in India
- 12.3.2. SpectraWAVE Secures 510(k) Clearance to Add Saline Imaging and Expanded Artificial Intelligence Features to the HyperVue Imaging System
- 12.3.3. Nikon Introduces the AX R MP with NSPARC Super-resolution Multiphoton Confocal Microscope
- 12.3.4. Photonis Announces Agreement to Acquire Telops, a min Hyperspectral Infra-Red Imaging Solutions
- 12.3.5. Olympus Launches VISERA ELITE III Surgical Visualization Platform
- 12.3.6. Shimadzu Unveils Near-Infrared Light Imaging System to Enhance Drug Discovery Research
- 12.3.7. Getinge Acquires Expert in Near Infrared Imaging Technology, Fluoptics
- 12.3.8. Emberion Raises EUR 6 million For its Infrared Imaging Business

13. Competitive Portfolio

13.1. Key Company Profiles
13.2. Key Product Portfolio